Encapsulation of Polyphenolic Preparation in Gelatin Fruit Jellies Slows the Digestive Release of Cholinesterase Inhibitors In Vitro. [PDF]
Szwajgier D +3 more
europepmc +1 more source
Repurposing Alzheimer's disease medications-systemic cholinesterase inhibitors-for the treatment of dry eye syndrome, glaucoma, and age-related macular degeneration. [PDF]
Rajagopal S +4 more
europepmc +1 more source
Efficient Access to New Thienobenzo-1,2,3-Triazolium Salts as Preferred Dual Cholinesterase Inhibitors. [PDF]
Mlakić M +8 more
europepmc +1 more source
Brain morphological characteristics predicting clinical response to selective serotonin reuptake inhibitors or cholinesterase inhibitors: A study of electronic medical records in patients with cognitive disorders. [PDF]
Onda K +8 more
europepmc +1 more source
Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies. [PDF]
Kassem AF +4 more
europepmc +1 more source
Related searches:
Applications of Cholinesterase Inhibitors
Lancet, The, 2001Peter Häussermann +1 more
exaly +5 more sources
Cholinesterase Inhibitors and Beyond
Current Alzheimer Research, 2009Cholinesterase inhibitors (ChEIs) were introduced in the therapy of Alzheimer Disease (AD) in the nineteen nineties with great expectations. The hopes and large interest raised by these drugs are well demonstrated by 12,000 references listed by PubMed under 'ChEI' for 1995-2007. The list is reduced to 2500 if we confine ourselves to 'ChEIs and dementia'
PEPEU, GIANCARLO +1 more
openaire +2 more sources

